Tag: BA2

Poster-Quality of Life and Outcomes

Examining Fatigue in Progressive MS: Results from a Qualitative Study and Review of PRO Measures

Background: Although fatigue is one of the most common symptoms of multiple sclerosis (MS) and several patient-reported outcome (PRO)...

Read More

Poster-Imaging

First Steps Towards Implementation of a Standardized MRI Protocol to Improve Care for People with MS in British Columbia

Background: Magnetic resonance imaging (MRI) is important in the diagnosis and monitoring of people with multiple sclerosis (MS). Using a...

Read More

Poster-Disease-modifying Therapy

Efficacy of Ofatumumab on Microglial Activity in Patients with Relapsing Forms of Multiple Sclerosis: Interim Analysis

INTRODUCTION Ofatumumab, a fully-human anti-CD20 monoclonal antibody, is indicated for the treatment of relapsing forms of multiple...

Read More

Poster-Family and Caregivers

Caregiving Challenges in Multiple Sclerosis and Alzheimer’s Disease: Results from a Caregiver Survey Study in Two Virtual Communities

Background: Being a caregiver for a family member with a chronic neurological disease is a role that is often simultaneously fulfilling and...

Read More

Poster-Disease-modifying Therapy

Multiple Sclerosis Disease Modifying Therapies’ Adherence and Total Medical Costs Among Women with Maternity Services Using Administrative Data.

Background: Women with multiple sclerosis (MS) who become pregnant and utilize maternity services may find their use of disease-modifying...

Read More

Poster-Disease-modifying Therapy

Adherence to Multiple Sclerosis Disease Modifying Therapies Using Pharmacy Quality Alliance Criteria and Medical Costs or Hospitalizations in an Administrative Database.

Background: Evidence is needed that adherence to disease-modifying therapies (DMT) for multiple sclerosis (MS) can reduce total medical...

Read More